Klinické štúdie CHOPN v štáte Florida
28 štúdií pre CHOPN hľadá účastníkov v zariadeniach v štáte Florida.
Mestá v štáte Florida
- Miami18 štúdií
- Orlando15 štúdií
- Hialeah8 štúdií
- Tampa7 štúdií
- Kendall7 štúdií
- West Palm Beach6 štúdií
- Jacksonville6 štúdií
- Ocala5 štúdií
- St. Petersburg4 štúdií
- Deltona4 štúdií
- Doral4 štúdií
- Boca Raton4 štúdií
- Brandon3 štúdií
- Plantation3 štúdií
- Cape Coral3 štúdií
- Clearwater3 štúdií
- Palm Coast3 štúdií
- Naples3 štúdií
Oficiálny text štúdie (anglicky)
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Boynton Beach
- Research Site, Bradenton
- Research Site, Cape Coral
- a 25 ďalších
Prebieha náborFáza 3
Vek 40 až 80 · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT06283966Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Meris Clinical Research- Site Number : 8400153, Brandon
- Hillcrest Medical Research- Site Number : 8400082, DeLand
- Finlay Medical Research - Greenacres- Site Number : 8400107, Greenacres City
- a 18 ďalších
Prebieha náborFáza 3
Vek 40 až 80 · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT07190222To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- International Clinical Research, Altamonte Springs
- Nature Coast Clinical Research, Crystal River
- Clinical Site Partners, LLC Leesburg dba Flourish Research, Leesburg
- a 2 ďalších
Prebieha náborFáza 2
Vek 40 až 85 · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT07684820A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)
- GSK Investigational Site, Miami
- GSK Investigational Site, Tampa
Prebieha náborFáza 3
Vek 40 až 80 · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT07780656A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- Millennium Medical Research - Miami, Miami
- Deluxe Health Center, Miami Lakes
- Florida Institute For Clinical Research, LLC, Orlando
Prebieha náborFáza 2
Vek 40 až 75 · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT07759245Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Helix Biomedics- Site Number : 8400065, Boynton Beach
- Beautiful Minds Clinical Research Center- Site Number : 8400017, Cutler Bay
- Eastern Medical Group Research- Site Number : 8400020, Fort Myers
- a 10 ďalších
Prebieha náborFáza 3
Vek 40 až 80 · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07190209A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
- University of Miami Dermatology Clinical Trials Unit- Site Number : 8400015, Miami
- Finlay Medical Research- Site Number : 8400010, Miami
Prebieha náborFáza 4
Vek 40 až 85 · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07053423A Study to Evaluate the Long-term Safety and Efficacy of Lunsekimig in Adult Participants With Chronic Obstructive Pulmonary Disease (COPD)
- Helix Biomedics- Site Number : 8403065, Boynton Beach
Prebieha náborFáza 3
Vek 40 až 80 · Všetky pohlavia · Aktualizované 21. 9. 2026 · NCT07793409An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
- Orlando Health, Orlando
Prebieha nábor
Vek 40 až 80 · Všetky pohlavia · Aktualizované 17. 9. 2026 · NCT06035120A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
- WB Contracted Clinical Research Site, Miami Lakes
Prebieha náborFáza 2
Vek 40 až 80 · Všetky pohlavia · Aktualizované 15. 9. 2026 · NCT07646587A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)
- GSK Investigational Site, Doral
Prebieha náborFáza 3
Vek 40 až 80 · Všetky pohlavia · Aktualizované 9. 9. 2026 · NCT07780669A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Brandon
- Research Site, Cape Coral
- Research Site, Clearwater
- a 17 ďalších
Prebieha náborFáza 2
Vek 40 a viac · Všetky pohlavia · Aktualizované 9. 9. 2026 · NCT07082738Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- University of Florida, Jacksonville
Prebieha náborFáza 2
Vek 40 a viac · Všetky pohlavia · Aktualizované 4. 9. 2026 · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Bay Pines
- Research Site, Boynton Beach
- Research Site, Jacksonville
- a 5 ďalších
Prebieha náborFáza 3
Vek 40 až 80 · Všetky pohlavia · Aktualizované 3. 9. 2026 · NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Clearwater
- Research Site, Cutler Bay
- Research Site, Cutler Bay
- a 9 ďalších
Prebieha náborFáza 3
Vek 40 až 80 · Všetky pohlavia · Aktualizované 3. 9. 2026 · NCT06883305A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Finlay Medical Research, Greenacres City
- Clinical Research Specialists LLC, Kissimmee
- Advanced Pulmonary Research Institute, Loxahatchee Groves
- a 9 ďalších
Prebieha náborFáza 2/3
Vek 35 až 80 · Všetky pohlavia · Aktualizované 31. 8. 2026 · NCT07363694Rademikibart IV for Acute Asthma and COPD Exacerbation
- Columbus Clinical Services, LLC, Miami
- Pharmax Research of South Florida, Inc., Miami
Prebieha náborFáza 2
Vek 18 až 85 · Všetky pohlavia · Aktualizované 27. 8. 2026 · NCT07705737Alpha-1 Research Registry
- Alpha-1 Foundation, Coral Gables
Prebieha náborObservačná štúdia
Všetky vekové kategórie · Všetky pohlavia · Aktualizované 19. 8. 2026 · NCT04157049A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 103, Gainesville
- GC2501 Study Site 105, Miami
Prebieha náborFáza 3
Vek 18 až 80 · Všetky pohlavia · Aktualizované 11. 8. 2026 · NCT07555483STRIVE Post-Market Registry Study
- University of Miami, Coral Gables
Prebieha náborObservačná štúdia
Vek 18 a viac · Všetky pohlavia · Aktualizované 3. 8. 2026 · NCT04302272eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, Brandon
- GSK Investigational Site, Crystal River
- GSK Investigational Site, Doral
- a 8 ďalších
Prebieha náborFáza 3
Vek 40 až 75 · Všetky pohlavia · Aktualizované 28. 7. 2026 · NCT07177339Physiologic Effects of Nasal High Flow on Exercise Tolerance in COPD
- University of Miami, Miami
Prebieha nábor
Vek 18 až 100 · Všetky pohlavia · Aktualizované 22. 6. 2026 · NCT06578156Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
- Mayo Clinic Jacksonville, Jacksonville
Prebieha nábor
Vek 40 až 80 · Všetky pohlavia · Aktualizované 28. 4. 2026 · NCT07051707Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
- Mayo Clinic, Jacksonville
- Orlando Health, Orlando
Prebieha nábor
Vek 40 až 84 · Všetky pohlavia · Aktualizované 24. 4. 2026 · NCT06891755Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Brooksville
- GSK Investigational Site, Doral
- GSK Investigational Site, Fort Lauderdale
- a 15 ďalších
Prebieha náborFáza 3
Vek 40 až 80 · Všetky pohlavia · Aktualizované 9. 4. 2026 · NCT06961214Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)
- GSK Investigational Site, Loxahatchee Groves
- GSK Investigational Site, Miami
Prebieha náborFáza 3
Vek 40 až 80 · Všetky pohlavia · Aktualizované 8. 10. 2025 · NCT06959095Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Hillcrest Medical Research, DeLand
- Universal Axon Clinical Research, Doral
- I.H.S Health, LLC, Kissimmee
- a 3 ďalších
Prebieha náborObservačná štúdia
Vek 50 a viac · Všetky pohlavia · Aktualizované 5. 8. 2025 · NCT06122077myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
- University of Florida, Jacksonville, Jacksonville
- Alloy Clinical Research, Kissimmee
- Reliable Research, Inc., Miami
- a 2 ďalších
Prebieha nábor
Vek 30 a viac · Všetky pohlavia · Aktualizované 6. 2. 2025 · NCT05204888Z ClinicalTrials.gov, dáta načítané 4. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.